Life Sciences
Chubb Launches New Life Science Package Policy
Chubb has designed an insurance package policy specifically to
meet the needs* of life science companies irrespective of their
size, stage of development or location.
At Chubb we offer more than just an insurance policy - we offer
a capability. Our offering includes wide coverage that grows as
our customer grows, coupled with award-winning service, claims
and loss-control.
The Life Science Package Policy can be tailored to meet the needs
of each individual client by combining the following coverage
options:
- Property Insurance:
- Property i.e. buildings, tenants improvements, stock,
computer equipment and machinery and plant
- Business Interruption including income from contract
research activities
- Research & Development Operations
- Research & Development Property i.e. cell
cultures, lab books, trial samples, prototypes
- Research & Development Expenditure i.e. monthly
burn
- Research & Development Income i.e. milestone
payments from collaboration agreements
- Committed Costs to Product Development Organisations
and other support organisations
- Contamination Incident and Radioactive Contamination
- protects property that is susceptible to contamination
from causes such as bacteria, micro-organisms
- Change in controlled Environment - protects property
in temperature or humidity controlled environments
i.e. cell cultures, master cell banks, trial samples
- Impairment
of Computer Services
- Money
- Property in Transit
- Contract Works
- Machinery Breakdown - protects laboratory and production
machinery such as bioreactors, cryogenic chambers,
capsule filling machines, tablet pressers
- Computer Breakdown
- UK Terrorism
- Commercial Liability Insurance:
- Public Liability
- Product Liability and Clinical
Trials
- Employers' Liability
- Product and Service Errors and Omissions
- Commercial Employee Fidelity Insurance
- Cancellation of Event Insurance
- Marine Insurance
For more details please click here.
*based on independent in-depth telephone interviews
carried out with life science companies in 2007.

|